ALKS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ALKS is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has a bullish short-term trend and positive analyst sentiment, but it is extended technically and lacks fresh news or a clear near-term catalyst. My direct view: hold off for now rather than buy aggressively at this level.
ALKS is in an uptrend: SMA_5 is above SMA_20 and SMA_200, and MACD histogram is positive and expanding, which supports bullish momentum. However, RSI_6 is 83.334, which is strongly overbought and suggests the current move may be stretched. Price at 40.26 is just above the pivot zone (38.218) and near first resistance (R1 39.952), with next resistance at 41.024. The trend is bullish, but the stock is extended and nearby resistance reduces immediate upside attractiveness.
Analysts also see long-term value from Alkermes' profitable base business and expanding orexin pipeline optionality.
No recent insider or hedge-fund accumulation trend is present; both are neutral. No recent congress trading data is available, and there is no evidence of politicians or influential figures buying or selling the stock recently. The lack of fresh supportive flow reduces urgency to buy now.
No latest-quarter financial snapshot was available in the provided data due to an error, so I cannot assess the most recent quarter's revenue or earnings trends directly. Based on analyst commentary, the company is still viewed as having a profitable base business expected to generate about $370M-$410M in adjusted EBITDA this year, which supports the long-term investment case, but the provided dataset does not include the latest quarter season figures.
Analyst trend is improving overall. Baird, Needham, UBS, RBC, and Piper all have positive views and several lifted price targets into the $44-$50 range. BofA remains the main cautious voice with a Neutral rating and a $36 target. Wall Street pros overall are bullish on long-term pipeline optionality and profitability, but the mixed ratings show the market is not unanimously convinced at current prices.
